App
Neuroscience for Performance, Resilience & ROI
From absenteeism to presenteeism, stress-related challenges cost the U.S. economy up to $550 billion annually. Traditional wellness perks aren’t enough — forward-thinking organizations need Brain Capital strategies to gain a true competitive edge.
Charles Schwab recognized this opportunity and partnered with Vitanya to launch a groundbreaking pilot aimed at reducing cognitive strain and optimizing brain performance among their veteran workforce.
The 6-month Charles Schwab pilot deployed Vitanya’s system to address sleep, boost executive function, and improve overall quality of life for employees — while elevating productivity for the organization.
Figures above are the self-reported outcomes published by Vitanya for this pilot, reproduced here as stated. Self-report is a participant measure, not a controlled clinical trial result.
Beyond impressive results, this pilot demonstrated that Brain Capital is today’s competitive advantage. Resilient brains lead to better performance, fewer errors, higher engagement, and stronger team dynamics - all of which directly impact the bottom line.
Companies that invest in Brain Capital aren't just supporting employee wellness — they’re fueling innovation, accelerating productivity, and positioning themselves for long-term success.
Bring us the population and the outcome you are accountable for. We will show you how the baseline is set, what gets measured, and what your leadership would read at the end of it.
